RBC Capital maintains NICE at Outperform, lowers price target to $130 from $145
RBC Capital maintained its Outperform rating for NICE but reduced its price target to $130 from $145, a 10.3% decrease. This implies a 99.6% downside from NICE's Nov 5 close of $315.80, according to the firm.
How this was made
The 30-second read
Why it matters
The downgrade may trigger short-term selling pressure and affect analyst consensus.
Market read
Analyst target cuts are a common catalyst for modest price moves; traders may adjust positions accordingly.
What to watch
Potential upcoming product launches or contract wins not yet reflected in the target.
Background
RBC Capital issued a new research note lowering its price target for NICE.
Ticker impact
RBC Capital lowered NICE's price target to $130 from $145, indicating a bearish outlook.
likely downward pressure as investors price in the reduced target
Target reduction is a fresh analyst action; no other new catalyst, so price may adjust modestly.
Market effects
May weigh on the broader software/services sector as analysts reassess valuations.
Limited to markets where NICE trades (US and Europe).
Low; impact confined to NICE and close peers.
Counterpoint
Some investors may view the cut as an overreaction and see buying opportunity.
Key entities
- Research FirmRBC Capital
Provided the updated price target and rating.
- CompanyNICE Ltd
Subject of the analyst's revised target.
